USPTO serial 79428120
JUVESEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 14, 2026
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with JUVESEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Aloe vera preparations for cosmetic purposes; cosmetic sun-protecting preparations; cosmetic body creams; cleaning oils for cosmetic purposes; cosmetic acne creams, namely, non-medicated face and body creams to improve the appearance of acne; cosmetic acne cleansers, namely, non-medicated face and body cleansers to clean skin affected by acne; cosmetic preparations for baths; cosmetic creams; cosmetic creams for firming the skin; cosmetic creams for toning the skin; cosmetic eye gels; cosmetic masks; cosmetic milks; cosmetic skin moisturisers; cosmetic preparations adapted for sun-tanning; cosmetic preparations for skin care; cosmetic preparations for use in suntanning; cosmetic preparations for protection against the sun; cosmetic preparations for protecting the skin from sunburn; cosmetic preparations for the treatment of dry skin; cosmetic preparations for use on the hair; cosmetic preparations for use on the skin; cosmetic preparations for use on the skin to remove pigmentation marks; dermatological cosmetic preparations, namely, cosmetic skin care preparations to improve the appearance of the skin; cosmetic facial care preparations; cosmetic facial creams; cosmetic facial masks; cosmetic facial moisturisers; cosmetic facial scrubs; cosmetic facial toners; cosmetic facial washes; facial wipes impregnated with cosmetics; gel eye patches for cosmetic purposes; cosmetic hair care preparations; cosmetic beauty masks for the face; cosmetic preparations in the form of mineral water sprays for cosmetic purposes; skin moisturisers used as cosmetics; moisturising cosmetic body lotions; cosmetic moisturising creams; cosmetic skin moisturising gels; cosmetic moisturising skin creams; cosmetic moisturising skin lotions; cosmetic night creams; non-medicated cosmetic preparations; non-medicated cosmetics; non-medicated cosmetic skin care lotions; non-medicated cosmetic nourishing creams; oils for cosmetic purposes; cosmetic skin care creams; skin care oils for cosmetic purposes; cosmetic skin care preparations; non-medicated cosmetic skin cleaners; cosmetic skin cleansing cream; cosmetic skin cleansing preparations; skin creams for cosmetic purposes; cosmetic preparations for slimming purposes, other than for medical use; cosmetic body sprays; cosmetic sun blocking cream; cosmetic sun blocking gel; cosmetic sun blocking lipsticks; cosmetic sun blocking lotions; cosmetic sun blocking oils; cosmetic sun creams; cosmetic sun gel; cosmetic sun lotions; cosmetic sun milk lotions; cosmetic sun protecting creams; cosmetic sun skin care products being after-sun milks, gels, oils, lotions, creams and moisturisers; cosmetic sun-tanning preparations; cosmetic sun screen preparations; cosmetic sun protection preparations; cosmetic suntan lotion; cosmetic suntan milk; cosmetic suntan oils; cosmetic suntan preparations | ACTIVE | — |
| 005 | Acai powder dietary supplements; dietary supplements, namely, antioxidants; dietary supplements with a cosmetic effect; dietary supplements comprised of bee glue, namely, propolis; carbohydrate based dietary supplements; casein dietary supplements; dietary food supplements; dietary and nutritional supplements; dietary supplements for animals; dietary supplements; dietary supplements for infants; dietary protein supplements; enzyme dietary supplements; flavonoids for use as a dietary supplement; glucose dietary supplements; nutritional drinks being dietary food supplements in beverage form; plant compounds for use as dietary supplements for medicinal use; plant compounds for use as dietary supplements for veterinary use; plant extracts, other than essential oils for use as dietary supplements; pharmaceutical acne treatment preparations in the form of cleansers; pharmaceutical acne treatment preparations in the form of creams; self-adhesive dressings containing pharmaceutical preparations, for medical and veterinary purposes; aloe vera preparations for pharmaceutical purposes; anti-bacterial pharmaceutical preparations; anti-sunburn preparations for pharmaceutical use; anti-cancer pharmaceutical preparations; antihypertensive pharmaceutical preparations, namely, pharmaceutical preparations for treating hypertension; capsules sold empty for pharmaceutical purposes; capsules sold empty for veterinary pharmaceutical preparations; pharmaceutical preparations, namely, elixirs for eliminating toxins from the body; effervescent pharmaceutical preparations, being vitamin supplements; extracts of plants, other than essential oils, in capsule form for pharmaceutical use; medicated lozenges for pharmaceutical purposes; medicated lotions for pharmaceutical purposes for treating dermatological conditions; medicated moisturising body lotion for pharmaceutical purposes; medicated moisturisers for pharmaceutical purposes; medicated moisturising creams for pharmaceutical purposes; medicated moisturising gels for pharmaceutical purposes; medicated moisturising lotions for pharmaceutical purposes; natural pharmaceutical preparations for skin care; medicated skin care preparations, namely, creams for pharmaceutical purposes; pharmaceutical preparations containing vitamins for medical use, namely, vitamin supplements; pharmaceutical preparations for alleviating disorders of the brain; pharmaceutical preparations for skin care for animals; pharmaceutical preparations for assisting the prevention of bone diseases; pharmaceutical preparations for nasal use, being nasal sprays and nasal drops for medical purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention of cardiovascular disorders; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for the relief of insect stings; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceutical preparations for the treatment of alcoholism; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of blackheads, being medicated skincare preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for the treatment of depressive illness; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of digestive maladies, namely, pharmaceutical preparations affecting digestive organs; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of disorders of the gastro-enterological tract; pharmaceutical preparations for the treatment of gastric diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of joint related diseases; pharmaceutical skin care preparations for the treatment of pimples; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical skin care preparations for the treatment of skin spots; pharmaceutical preparations for the treatment of eye conditions and diseases; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for use in dentistry, being medicines for dental purposes; pharmaceutical preparations for use in hypercholesterolemia therapy; pharmaceutical preparations for use in the treatment of arthritis; pharmaceutical preparations for use in the treatment of colostomy patients; pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations for use in the treatment of rheumatism; pharmaceutical skin care preparations for use in the treatment of skin blemishes; pharmaceutical preparations for use in the treatment seborrheic dermatitis; pharmaceutical preparations in the form of lozenges for treating sore throats; pharmaceutical products derived from natural sources, being natural herbal supplements, natural sleep aid preparations and natural dietary supplements; pharmaceutical products for combating heart diseases; pharmaceutical products for combating metabolism disorders; pharmaceutical products for metabolic disorders; pharmaceutical products for the central nervous system; pharmaceutical products for the stimulation of growth, being human growth hormone; pharmaceutical products for the treatment of blood circulation diseases; pharmaceutical products for the treatment of cardiovascular disorders; pharmaceutical products for the treatment of dysfunctions of metabolism; pharmaceutical products for the treatment of gastrointestinal disorders; pharmaceutical products for the treatment of osteoporosis; pharmaceutical tonic preparations, being dietetic beverages adapted for medical purposes; plant extracts, other than essential oils, for pharmaceutical purposes; plant extracts, other than essential oils, for pharmaceutical use; pharmaceutical preparations for application to the scalp, being medicated scalp care preparations; pharmaceutical skin care preparations for application to the skin; pharmaceutical preparations for body care, being medicated body powder and medicated body lotions; pharmaceutical preparations for nails, being preparations to prevent nail-biting and to treat nail fungus; pharmaceutical preparations for sun protection, namely, medicated sun care preparations; preparations of activated powdered or granulated carbon and of charcoal for pharmaceutical use; nutritional supplements in the form of syrups for pharmaceutical purposes; tissue-regenerative pharmaceutical preparations; babies' beverages; dietetic beverages adapted for medical purposes; nutritional dietetic beverages adapted for medicinal purposes; dietetic beverages containing added minerals adapted for medical purposes; dietetic beverages containing added trace elements adapted for medical purposes; dietetic beverages containing added vitamins adapted for medical purposes; beverages for infants; electrolyte replacement beverages for medical purposes; herbal dietetic beverages adapted for medicinal use; malted milk beverages for medical purposes; medicated tisanes, being dietetic beverages adapted for medical purposes; medicated tonic water, being dietetic beverages adapted for medical purposes; demineralised water being a dietetic beverage adapted for medical use; mineral, vitamin, and nutritionally enhanced waters being beverages for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 14, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 26, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 27, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 17, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 17, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 3, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 2, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 31, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 17, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |